PAUL L BERNS Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for PAUL L BERNS.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of PAUL L BERNS. PAUL L BERNS is Chief Executive Officer in ALLOS THERAPEUTICS INC ($ALTH).
Latest Insider Trading Transactions of PAUL L BERNS
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 05 2012 | ALTH | ALLOS THERAPEUTICS ... | BERNS PAUL L | Chief Executive Off ... | Sell | U | 1.82 | 1,233,323 | 2,244,648 | 0 | 1.2 M to 0 (-100.00 %) |
| Mar 01 2012 | ALTH | ALLOS THERAPEUTICS ... | BERNS PAUL L | Chief Executive Off ... | Sell | S | 1.48 | 21,532 | 31,816 | 1,233,323 | 1.3 M to 1.2 M (-1.72 %) |
| Mar 01 2012 | ALTH | ALLOS THERAPEUTICS ... | BERNS PAUL L | Chief Executive Off ... | Sell | S | 1.52 | 21,163 | 32,235 | 1,254,855 | 1.3 M to 1.3 M (-1.66 %) |
| Mar 01 2012 | ALTH | ALLOS THERAPEUTICS ... | BERNS PAUL L | Chief Executive Off ... | Grant | A | 0.00 | 573,506 | 0 | 1,276,018 | 702.5 K to 1.3 M (+81.64 %) |
| Feb 27 2012 | ALTH | ALLOS THERAPEUTICS ... | BERNS PAUL L | Chief Executive Off ... | Sell | S | 1.55 | 4,350 | 6,743 | 702,512 | 706.9 K to 702.5 K (-0.62 %) |
| Feb 27 2012 | ALTH | ALLOS THERAPEUTICS ... | BERNS PAUL L | Chief Executive Off ... | Sell | S | 1.56 | 9,100 | 14,196 | 706,862 | 716 K to 706.9 K (-1.27 %) |
| Nov 17 2011 | ALTH | ALLOS THERAPEUTICS ... | BERNS PAUL L | Chief Executive Off ... | Sell | S | 1.43 | 450 | 644 | 715,962 | 716.4 K to 716 K (-0.06 %) |
| Nov 17 2011 | ALTH | ALLOS THERAPEUTICS ... | BERNS PAUL L | Chief Executive Off ... | Sell | S | 1.46 | 31,817 | 46,532 | 716,412 | 748.2 K to 716.4 K (-4.25 %) |
| Mar 18 2011 | ALTH | ALLOS THERAPEUTICS ... | BERNS PAUL L | Chief Executive Off ... | Option Exercise | M | 3.14 | 2,500 | 7,850 | 347,500 | |
| Mar 18 2011 | ALTH | ALLOS THERAPEUTICS ... | BERNS PAUL L | Chief Executive Off ... | Buy | M | 3.14 | 2,500 | 7,850 | 748,229 | 745.7 K to 748.2 K (+0.34 %) |
| Mar 02 2011 | ALTH | ALLOS THERAPEUTICS ... | BERNS PAUL L | Chief Executive Off ... | Grant | A | 0.00 | 345,942 | 0 | 745,729 | 399.8 K to 745.7 K (+86.53 %) |
| Feb 25 2011 | ALTH | ALLOS THERAPEUTICS ... | BERNS PAUL L | Chief Executive Off ... | Sell | S | 3.12 | 4,255 | 13,293 | 399,787 | 404 K to 399.8 K (-1.05 %) |
| Feb 25 2011 | ALTH | ALLOS THERAPEUTICS ... | BERNS PAUL L | Chief Executive Off ... | Sell | S | 3.25 | 9,193 | 29,878 | 404,042 | 413.2 K to 404 K (-2.22 %) |
| Oct 22 2010 | ALTH | ALLOS THERAPEUTICS ... | BERNS PAUL L | Chief Executive Off ... | Grant | A | 0.00 | 265,734 | 0 | 413,235 | 147.5 K to 413.2 K (+180.16 %) |
| Mar 11 2010 | ALTH | ALLOS THERAPEUTICS ... | BERNS PAUL L | Chief Executive Off ... | Sell | D | 7.45 | 41,350 | 308,157 | 147,501 | 188.9 K to 147.5 K (-21.90 %) |
| Mar 11 2010 | ALTH | ALLOS THERAPEUTICS ... | BERNS PAUL L | Chief Executive Off ... | Sell | D | 7.25 | 33,650 | 244,010 | 188,851 | 222.5 K to 188.9 K (-15.12 %) |
| Feb 24 2010 | ALTH | ALLOS THERAPEUTICS ... | BERNS PAUL L | Chief Executive Off ... | Option Exercise | A | 7.56 | 170,000 | 1,285,200 | 170,000 | |
| Feb 24 2010 | ALTH | ALLOS THERAPEUTICS ... | BERNS PAUL L | Chief Executive Off ... | Sell | S | 7.57 | 7,362 | 55,766 | 222,501 | 229.9 K to 222.5 K (-3.20 %) |
| Feb 24 2010 | ALTH | ALLOS THERAPEUTICS ... | BERNS PAUL L | Chief Executive Off ... | Sell | S | 7.51 | 4,304 | 32,331 | 229,863 | 234.2 K to 229.9 K (-1.84 %) |
| Feb 24 2010 | ALTH | ALLOS THERAPEUTICS ... | BERNS PAUL L | Chief Executive Off ... | Grant | A | 0.00 | 100,000 | 0 | 234,167 | 134.2 K to 234.2 K (+74.53 %) |
| Feb 10 2010 | ALTH | ALLOS THERAPEUTICS ... | BERNS PAUL L | Chief Executive Off ... | Sell | S | 7.00 | 32,580 | 228,086 | 134,167 | 166.7 K to 134.2 K (-19.54 %) |
| Jan 12 2010 | ALTH | ALLOS THERAPEUTICS ... | BERNS PAUL L | Chief Executive Off ... | Sell | S | 7.00 | 65,160 | 456,120 | 166,747 | 231.9 K to 166.7 K (-28.10 %) |
| Aug 12 2009 | ALTH | ALLOS THERAPEUTICS ... | BERNS PAUL L | Chief Executive Off ... | Option Exercise | M | 3.14 | 342,000 | 1,073,880 | 350,000 | |
| Aug 12 2009 | ALTH | ALLOS THERAPEUTICS ... | BERNS PAUL L | Chief Executive Off ... | Sell | S | 8.24 | 342,000 | 2,819,311 | 231,907 | 573.9 K to 231.9 K (-59.59 %) |
| Aug 12 2009 | ALTH | ALLOS THERAPEUTICS ... | BERNS PAUL L | Chief Executive Off ... | Buy | M | 3.14 | 342,000 | 1,073,880 | 573,907 | 231.9 K to 573.9 K (+147.47 %) |
| Aug 07 2009 | ALTH | ALLOS THERAPEUTICS ... | BERNS PAUL L | Chief Executive Off ... | Option Exercise | M | 3.14 | 8,000 | 25,120 | 692,000 | |
| Aug 07 2009 | ALTH | ALLOS THERAPEUTICS ... | BERNS PAUL L | Chief Executive Off ... | Sell | S | 8.14 | 8,000 | 65,150 | 231,907 | 239.9 K to 231.9 K (-3.33 %) |
| Aug 07 2009 | ALTH | ALLOS THERAPEUTICS ... | BERNS PAUL L | Chief Executive Off ... | Buy | M | 3.14 | 8,000 | 25,120 | 239,907 | 231.9 K to 239.9 K (+3.45 %) |
| Mar 12 2009 | ALTH | ALLOS THERAPEUTICS ... | BERNS PAUL L | Chief Executive Off ... | Sell | D | 6.54 | 34,235 | 224,000 | 231,907 | 266.1 K to 231.9 K (-12.86 %) |
| Feb 25 2009 | ALTH | ALLOS THERAPEUTICS ... | BERNS PAUL L | Chief Executive Off ... | Option Exercise | A | 6.40 | 280,000 | 1,792,000 | 280,000 | |
| Feb 25 2009 | ALTH | ALLOS THERAPEUTICS ... | BERNS PAUL L | Chief Executive Off ... | Grant | A | 0.00 | 46,667 | 0 | 266,142 | 219.5 K to 266.1 K (+21.26 %) |
| Mar 12 2008 | ALTH | ALLOS THERAPEUTICS ... | BERNS PAUL L | Chief Executive Off ... | Sell | S | 5.52 | 200 | 1,104 | 254,475 | 254.7 K to 254.5 K (-0.08 %) |
| Mar 12 2008 | ALTH | ALLOS THERAPEUTICS ... | BERNS PAUL L | Chief Executive Off ... | Sell | S | 5.51 | 4,400 | 24,244 | 254,675 | 259.1 K to 254.7 K (-1.70 %) |
| Mar 12 2008 | ALTH | ALLOS THERAPEUTICS ... | BERNS PAUL L | Chief Executive Off ... | Sell | S | 5.46 | 297 | 1,622 | 259,075 | 259.4 K to 259.1 K (-0.11 %) |
| Mar 12 2008 | ALTH | ALLOS THERAPEUTICS ... | BERNS PAUL L | Chief Executive Off ... | Sell | S | 5.45 | 1,703 | 9,281 | 259,372 | 261.1 K to 259.4 K (-0.65 %) |
| Mar 12 2008 | ALTH | ALLOS THERAPEUTICS ... | BERNS PAUL L | Chief Executive Off ... | Sell | S | 5.43 | 1,100 | 5,973 | 261,075 | 262.2 K to 261.1 K (-0.42 %) |
| Mar 12 2008 | ALTH | ALLOS THERAPEUTICS ... | BERNS PAUL L | Chief Executive Off ... | Sell | S | 5.42 | 2,200 | 11,924 | 262,175 | 264.4 K to 262.2 K (-0.83 %) |
| Mar 12 2008 | ALTH | ALLOS THERAPEUTICS ... | BERNS PAUL L | Chief Executive Off ... | Sell | S | 5.40 | 3,000 | 16,200 | 264,375 | 267.4 K to 264.4 K (-1.12 %) |
| Mar 12 2008 | ALTH | ALLOS THERAPEUTICS ... | BERNS PAUL L | Chief Executive Off ... | Sell | S | 5.36 | 8,319 | 44,590 | 267,375 | 275.7 K to 267.4 K (-3.02 %) |
| Mar 12 2008 | ALTH | ALLOS THERAPEUTICS ... | BERNS PAUL L | Chief Executive Off ... | Sell | S | 5.35 | 9,481 | 50,723 | 275,694 | 285.2 K to 275.7 K (-3.32 %) |
| Mar 12 2008 | ALTH | ALLOS THERAPEUTICS ... | BERNS PAUL L | Chief Executive Off ... | Sell | S | 5.29 | 2,600 | 13,754 | 285,175 | 287.8 K to 285.2 K (-0.90 %) |
| Mar 12 2008 | ALTH | ALLOS THERAPEUTICS ... | BERNS PAUL L | Chief Executive Off ... | Sell | S | 5.20 | 100 | 520 | 287,775 | 287.9 K to 287.8 K (-0.03 %) |
| Mar 12 2008 | ALTH | ALLOS THERAPEUTICS ... | BERNS PAUL L | Chief Executive Off ... | Sell | S | 5.19 | 1,000 | 5,190 | 287,875 | 288.9 K to 287.9 K (-0.35 %) |
| Feb 27 2008 | ALTH | ALLOS THERAPEUTICS ... | BERNS PAUL L | Chief Executive Off ... | Option Exercise | A | 6.12 | 275,000 | 1,683,000 | 275,000 | |
| Jan 03 2008 | ALTH | ALLOS THERAPEUTICS ... | BERNS PAUL L | Chief Executive Off ... | Buy | P | 3.89 | 5,000 | 19,465 | 288,875 | 283.9 K to 288.9 K (+1.76 %) |
| Mar 14 2007 | ALTH | ALLOS THERAPEUTICS ... | BERNS PAUL L | Chief Executive Off ... | Sell | S | 6.45 | 23,625 | 152,466 | 283,875 | 307.5 K to 283.9 K (-7.68 %) |
| Feb 20 2007 | ALTH | ALLOS THERAPEUTICS ... | BERNS PAUL L | Chief Executive Off ... | Option Exercise | A | 7.47 | 275,000 | 2,054,250 | 275,000 | |
| Jan 03 2007 | ALTH | ALLOS THERAPEUTICS ... | BERNS PAUL L | Chief Executive Off ... | Buy | P | 3.05 | 2,500 | 7,629 | 307,500 | 305 K to 307.5 K (+0.82 %) |
| Apr 17 2006 | ALTH | ALLOS THERAPEUTICS ... | BERNS PAUL L | Chief Executive Off ... | Buy | P | 2.94 | 5,000 | 14,700 | 305,000 | 300 K to 305 K (+1.67 %) |
Page: 1